• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有细胞通透性的镧系元素-铂(IV)抗癌前药。

Cell-permeable lanthanide-platinum(IV) anti-cancer prodrugs.

机构信息

Chemistry Research Laboratory, University of Oxford, Mansfield Road, OX1 3TA, UK.

Department of Earth Sciences, University of Oxford, OX1 3AN, UK.

出版信息

Dalton Trans. 2021 Jun 29;50(25):8761-8767. doi: 10.1039/d1dt01688a.

DOI:10.1039/d1dt01688a
PMID:34080595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8237448/
Abstract

Platinum compounds are a vital part of our anti-cancer arsenal, and determining the location and speciation of platinum compounds is crucial. We have synthesised a lanthanide complex bearing a salicylic group (Ln = Gd, Eu) which demonstrates excellent cellular accumulation and minimal cytotoxicity. Derivatisation enabled access to bimetallic lanthanide-platinum(ii) and lanthanide-platinum(iv) complexes. Luminescence from the europium-platinum(iv) system was quenched, and reduction to platinum(ii) with ascorbic acid resulted in a "switch-on" luminescence enhancement. We used diffusion-based 1H NMR spectroscopic methods to quantify cellular accumulation. The gadolinium-platinum(ii) and gadolinium-platinum(iv) complexes demonstrated appreciable cytotoxicity. A longer delay following incubation before cytotoxicity was observed for the gadolinium-platinum(iv) compared to the gadolinium-platinum(ii) complex. Functionalisation with octanoate ligands resulted in enhanced cellular accumulation and an even greater latency in cytotoxicity.

摘要

铂化合物是我们抗癌武器库中的重要组成部分,确定铂化合物的位置和形态至关重要。我们合成了一种含有水杨酸基团的镧系元素配合物(Ln = Gd,Eu),该配合物具有出色的细胞积累能力和最小的细胞毒性。衍生化使我们能够获得双金属镧系元素-铂(ii)和镧系元素-铂(iv)配合物。铕-铂(iv)体系的发光被猝灭,用抗坏血酸还原为铂(ii)导致“开启”发光增强。我们使用基于扩散的 1H NMR 光谱方法来定量细胞积累。镓-铂(ii)和镓-铂(iv)配合物表现出相当大的细胞毒性。与镓-铂(ii)配合物相比,观察到镓-铂(iv)配合物在孵育后出现更长的延迟才表现出细胞毒性。用辛酸酯配体进行功能化可提高细胞积累,并使细胞毒性的潜伏期更长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/17e311ba55cf/d1dt01688a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/9d80bf53733f/d1dt01688a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/027f4f6f95eb/d1dt01688a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/4baac56bc260/d1dt01688a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/d76f4fa0c44f/d1dt01688a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/5bfb3621799c/d1dt01688a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/17e311ba55cf/d1dt01688a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/9d80bf53733f/d1dt01688a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/027f4f6f95eb/d1dt01688a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/4baac56bc260/d1dt01688a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/d76f4fa0c44f/d1dt01688a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/5bfb3621799c/d1dt01688a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd5/8237448/17e311ba55cf/d1dt01688a-f5.jpg

相似文献

1
Cell-permeable lanthanide-platinum(IV) anti-cancer prodrugs.具有细胞通透性的镧系元素-铂(IV)抗癌前药。
Dalton Trans. 2021 Jun 29;50(25):8761-8767. doi: 10.1039/d1dt01688a.
2
Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs.优化轴向配体以促进 BODIPY 缀合的顺铂(IV)抗癌前药的光活化。
Dalton Trans. 2021 Oct 12;50(39):13737-13747. doi: 10.1039/d1dt02362d.
3
The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.赤道配体对铂(IV)前药的氧化还原行为、细胞积累模式和细胞毒性的作用。
J Inorg Biochem. 2016 Jul;160:264-74. doi: 10.1016/j.jinorgbio.2016.03.005. Epub 2016 Mar 17.
4
Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs.荧光铂(IV)配合物作为设计缺氧激活型铂(IV)前药的潜在预测物。
Dalton Trans. 2024 Sep 10;53(35):14811-14816. doi: 10.1039/d4dt02173h.
5
Exploring the Structure-Activity Relationships of Albumin-Targeted Picoplatin-Based Platinum(IV) Prodrugs.探索白蛋白靶向的基于吡啶铂的铂(IV)前药的构效关系。
Inorg Chem. 2025 Feb 10;64(5):2554-2566. doi: 10.1021/acs.inorgchem.4c05269. Epub 2025 Jan 29.
6
Organelle-targeted BODIPY-conjugated platinum(IV) anticancer prodrugs for overcoming drug resistance.用于克服耐药性的细胞器靶向硼二吡咯共轭铂(IV)抗癌前药
Dalton Trans. 2025 Apr 1;54(14):5849-5858. doi: 10.1039/d4dt03249g.
7
Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells.对肝癌细胞具有选择性的乳清酸缺氧激活铂(IV)前药
Inorg Chem. 2021 Apr 5;60(7):4342-4346. doi: 10.1021/acs.inorgchem.0c03803. Epub 2021 Mar 12.
8
Platinum(II/IV) complexes with -substituted carboxylate ethylenediamine/propylenediamine ligands: preparation, characterization and activity.含β-取代羧酸根乙二胺/丙二胺配体的铂(II/IV)配合物:制备、表征及活性
Dalton Trans. 2025 Feb 25;54(9):3597-3609. doi: 10.1039/d4dt03041a.
9
Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.用于对抗耐药性和肿瘤转移的异核铂(IV)-钌(II)抗癌前药。
Chem Commun (Camb). 2016 Sep 14;52(71):10735-8. doi: 10.1039/c6cc04354b. Epub 2016 Aug 10.
10
A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.一种癌细胞选择性且低毒的双功能异双核铂(IV)-钌(II)抗癌前药。
Inorg Chem. 2018 Mar 5;57(5):2917-2924. doi: 10.1021/acs.inorgchem.8b00053. Epub 2018 Feb 13.

引用本文的文献

1
Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity.Pt(IV) 配合物在新型铂前药探索中的应用:具有潜在活性的药物。
Top Curr Chem (Cham). 2024 Feb 24;382(1):6. doi: 10.1007/s41061-023-00448-3.
2
Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models.具有显著抗癌活性的铂(IV)-金(I)制剂:二维和三维三阴性乳腺癌模型中的精选研究
Chemistry. 2023 Oct 23;29(59):e202302045. doi: 10.1002/chem.202302045. Epub 2023 Sep 5.
3
Promising heterometallic compounds as anticancer agents: Recent studies in vivo.

本文引用的文献

1
Gd(iii)-Pt(iv) theranostic contrast agents for tandem MR imaging and chemotherapy.用于串联磁共振成像和化疗的钆(III)-铂(IV)诊疗一体化造影剂。
Chem Sci. 2020 Jan 28;11(9):2524-2530. doi: 10.1039/c9sc05937g.
2
Oxaliplatin and [Pt(R,R-DACH)(panobinostat)] show nanomolar cytotoxicity towards diffuse intrinsic pontine glioma (DIPG).奥沙利铂和[Pt(R,R-DACH)(panobinostat)]对弥漫性内在脑桥神经胶质瘤(DIPG)表现出纳摩尔级别的细胞毒性。
Dalton Trans. 2020 May 7;49(17):5703-5710. doi: 10.1039/c9dt04862f. Epub 2020 Apr 16.
3
Stereoselective Formation of Facial Tris-Cyclometalated Pt Complexes: Dual Phosphorescence from Heteroleptic Derivatives.
具有前景的杂金属化合物作为抗癌剂:体内的最新研究。
Curr Opin Chem Biol. 2023 Feb;72:102250. doi: 10.1016/j.cbpa.2022.102250. Epub 2022 Dec 23.
面式三金属环化铂配合物的立体选择性形成:杂配衍生物的双重磷光
Chemistry. 2020 Sep 1;26(49):11307-11315. doi: 10.1002/chem.202001164. Epub 2020 Jul 28.
4
Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents.奥沙利铂 Pt(IV)前药与钆特沙吡啉偶联作为潜在的抗肿瘤药物。
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7021-7029. doi: 10.1073/pnas.1914911117. Epub 2020 Mar 16.
5
Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances.基于 Gd(III)的对比剂的分子磁共振成像:挑战与关键进展。
J Am Chem Soc. 2019 Oct 30;141(43):17025-17041. doi: 10.1021/jacs.9b09149. Epub 2019 Oct 17.
6
INDIANA: An in-cell diffusion method to characterize the size, abundance and permeability of cells.印第安纳州:一种用于细胞内扩散方法,可用于描述细胞的大小、丰度和渗透性。
J Magn Reson. 2019 May;302:1-13. doi: 10.1016/j.jmr.2018.12.001. Epub 2019 Jan 6.
7
Quantification of energy transfer in bimetallic Pt(ii)-Ln(iii) complexes featuring an N^C^N-cyclometallating ligand.测定具有 N^C^N 配位的金属铂(ii)-镧(iii)配合物中的能量转移。
Dalton Trans. 2019 Feb 5;48(6):2142-2149. doi: 10.1039/c8dt04640a.
8
A Ratiometric Fluorescent Probe for Cisplatin: Investigating the Intracellular Reduction of Platinum(IV) Prodrug Complexes.一种用于顺铂的比率荧光探针:研究铂(IV)前药复合物的细胞内还原。
Angew Chem Int Ed Engl. 2019 Jan 2;58(1):164-167. doi: 10.1002/anie.201810361. Epub 2018 Dec 4.
9
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.磁共振成像对比剂的化学:当前的挑战与新前沿。
Chem Rev. 2019 Jan 23;119(2):957-1057. doi: 10.1021/acs.chemrev.8b00363. Epub 2018 Oct 16.
10
Lanthanide-based tools for the investigation of cellular environments.基于镧系元素的工具用于研究细胞环境。
Chem Commun (Camb). 2018 Sep 6;54(72):10021-10035. doi: 10.1039/c8cc05271a.